# ACT MALI: Treatment of Malaria Based on Combination Therapies

> **NCT00452907** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 780 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Artesunate
- **DRUG:** Artesunate + Sulfadoxine-Pyrimethamine
- **DRUG:** arthemether + lumefantrine

## Key facts

- **NCT ID:** NCT00452907
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 780 (ACTUAL)
- **Last updated:** 2010-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00452907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00452907, "ACT MALI: Treatment of Malaria Based on Combination Therapies". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00452907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*